Literature DB >> 3982453

Trends in the incidence of myocardial infarction and in associated mortality and morbidity in a large employed population, 1957-1983.

S Pell, W E Fayerweather.   

Abstract

We analyzed long-term trends in the incidence of a first acute myocardial infarction and in case-fatality rates among employees of the Du Pont Company from 1957 through 1983. A steady decline in incidence was observed among male employees. The annual age-adjusted rate in the 1957-1959 period was 3.19 per 1000, as compared with 2.29 per 1000 in the 1981-1983 period--a decline of 28.2 per cent. The rate of decline was higher among salaried (white-collar) employees than among production workers receiving hourly wages. No trend was seen among female employees, but the number of cases may have been to small to detect a decline. Beginning in 1969, the 24-hour case-fatality rate showed a moderate decline, but after 1975, there was a sharp drop in the 30-day case-fatality rate among persons who survived 24 hours after the attack. These declines did not begin until several years after the decline in incidence had begun. This study and others suggest that improved medical care probably made some contribution to the decline in mortality associated with coronary heart disease, but the major source of the decline has been a reduction in the incidence of the disease.

Entities:  

Mesh:

Year:  1985        PMID: 3982453     DOI: 10.1056/NEJM198504183121601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  34 in total

1.  A comparison of results of a national cholesterol and blood pressure screening with the NHANES II Study: implications for further emphasis on reducing cardiovascular risk among Americans.

Authors:  F W Fridinger; A W Jackson; J Andresen
Journal:  J Community Health       Date:  1992-08

2.  Long-term impact of smoking cessation on the incidence of coronary heart disease.

Authors:  A N Tosteson; M C Weinstein; L W Williams; L Goldman
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

3.  Geographic variation in the onset of decline of male ischemic heart disease mortality in The Netherlands.

Authors:  J P Mackenbach; C W Looman; A E Kunst
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

4.  Trends of mortality rates during the last thirty years in Greece.

Authors:  George Nikolaidis; Dimitrios Zavras; Dionysis Bonikos; John Kyriopoulos
Journal:  J Med Syst       Date:  2004-12       Impact factor: 4.460

5.  Geographic and socioeconomic variation in the onset of decline of coronary heart disease mortality in white women.

Authors:  S Wing; E Barnett; M Casper; H A Tyroler
Journal:  Am J Public Health       Date:  1992-02       Impact factor: 9.308

6.  The effects of workplace health promotion on absenteeism and employment costs in a large industrial population.

Authors:  R L Bertera
Journal:  Am J Public Health       Date:  1990-09       Impact factor: 9.308

7.  Occupational class and ischemic heart disease mortality in the United States and 11 European countries.

Authors:  A E Kunst; F Groenhof; O Andersen; J K Borgan; G Costa; G Desplanques; H Filakti; M do R Giraldes; F Faggiano; S Harding; C Junker; P Martikainen; C Minder; B Nolan; F Pagnanelli; E Regidor; D Vågerö; T Valkonen; J P Mackenbach
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

8.  Cost-utility analysis of early thrombolytic therapy.

Authors:  D Castiel; C Hervé; M Gaillard; J L Bollaert; M Soula
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

9.  [Total plasma cholesterol and HDL in a Swiss population: what attitude and norms should be adopted?].

Authors:  B Burnand; D Hausser; M Rickenbach; C Platsoukas; F Gutzwiller
Journal:  Soz Praventivmed       Date:  1988

10.  All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997.

Authors:  Kyle Steenland; Sherry Hu; James Walker
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.